Search

PROCEPT BioRobotics Corp

Abierto

SectorSanidad

17.79 -1.66

Resumen

Variación precio

24h

Actual

Mínimo

17.96

Máximo

18.82

Métricas clave

By Trading Economics

Ingresos

-27M

-58M

Ventas

11M

94M

BPA

-0.47

Margen de beneficios

-61.905

Empleados

888

EBITDA

5.1M

-24M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+20.92% upside

Dividendos

By Acuity

Próximas Ganancias

3 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

7.4M

1.1B

Apertura anterior

19.45

Cierre anterior

17.79

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

119 / 339 Clasificación en Healthcare

PROCEPT BioRobotics Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 sept 2026, 20:10 UTC

Macro Event

Procept Biorobotics Corp is trading modestly higher, following the Federal Reserve's 25 basis point rate hike amid ongoing inflation concerns and market volatility.

15 sept 2026, 23:21 UTC

Procept Biorobotics Corp shares are higher in after-market trading, despite broader market pressures from rising Treasury yields. No specific news was identified.

11 sept 2026, 20:08 UTC

Procept Biorobotics Corp is higher today, recovering from an earlier dip. The stock remains below its 20-day moving average after three lower closes.

10 sept 2026, 20:31 UTC

Procept Biorobotics Corp shares are higher in after-market hours following increased trading, reversing a trend of declines over the past three sessions.

9 sept 2026, 20:07 UTC

News

Procept Biorobotics shares are declining amid a class action lawsuit alleging misleading sales practices and inflated financial reporting.

8 sept 2026, 20:03 UTC

News

Procept Biorobotics Corp shares are lower as multiple securities class action lawsuits allege misleading inventory and sales practices, impacting investor sentiment.

4 sept 2026, 20:02 UTC

Procept Biorobotics shares are higher today, reflecting overall market strength since Thursday's close. No specific company news was identified to explain the movement.

3 sept 2026, 20:07 UTC

News

Procept Biorobotics shares decline amid a class action lawsuit alleging misleading sales figures and unsustainable inventory levels. The stock pulled back from earlier session highs.

2 sept 2026, 20:01 UTC

News

Procept Biorobotics Corp shares are higher today, reaching a peak cumulative return despite a class action lawsuit from Kaplan Fox & Kilsheimer LLP.

1 sept 2026, 20:04 UTC

News

Procept Biorobotics Corp shares are lower amid a class action lawsuit alleging misleading sales performance and concerns over excess inventory levels.

28 ago 2026, 19:46 UTC

Procept Biorobotics Corp shares are higher since Thursday's close, despite earlier declines during the session. No specific news was identified for today's movement.

26 ago 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit alleging securities fraud related to inflated handpiece sales, contributing to a decline in shares during Wednesday's session.

25 ago 2026, 19:46 UTC

Procept Biorobotics shares are higher today amid favorable market conditions, including lower crude oil prices and decreasing Treasury yields. No specific company news was identified.

24 ago 2026, 19:36 UTC

News

Procept Biorobotics faces multiple class action lawsuits alleging securities fraud, contributing to negative sentiment as shares trade lower today.

21 ago 2026, 23:26 UTC

Procept Biorobotics shares are higher in after-market trading, amid a broader market recovery following recent geopolitical tensions and their impact on energy prices.

20 ago 2026, 20:06 UTC

News

Shares of Procept Biorobotics Corp are lower following a class action lawsuit alleging false sales and revenue statements, impacting investor sentiment amid negative earnings reports.

19 ago 2026, 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit from Kaplan Fox & Kilsheimer LLP but shares are trading higher during Wednesday's session.

18 ago 2026, 19:16 UTC

Procept Biorobotics Corp shares are higher, trading near the upper end of their one-month range, despite pulling back from earlier session highs.

17 ago 2026, 19:56 UTC

News

Procept Biorobotics faces downward pressure amid class action lawsuits alleging securities fraud, contributing to negative sentiment and a decline since Friday's close.

14 ago 2026, 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

13 ago 2026, 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

12 ago 2026, 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

11 ago 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10 ago 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7 ago 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 ago 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 ago 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 ago 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 ago 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 jul 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

Comparación entre iguales

Cambio de precio

PROCEPT BioRobotics Corp previsión

Precio Objetivo

By TipRanks

20.92% repunte

Estimación a 12 Meses

Media 22.286 USD  20.92%

Máximo 28 USD

Mínimo 19 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para PROCEPT BioRobotics Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

10 ratings

3

Comprar

6

Mantener

1

Vender

Sentimiento

By Acuity

119 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.